Kjetil Taskén

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Molecular oncology

Journal of immunology (Baltimore, Md. : 1950)

Nature communications

Blood advances

University of Oslo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oslo Jul 01 2018

Norway

Professor :: Institute for Clinical Medicine

Oslo University Hospital Jan 01 2018

Norway

Head and Director :: Institute for Cancer Research

University of Oslo Aug 01 2008 - Jun 30 2018

Norway

Director and Professor :: Centre for Molecular Medicine Norway, Nordic EMBL Partnership

Universitetet i Oslo Feb 01 2001 - Jun 30 2018

Norway

Professor of Medicine :: Inst. Basic Med. Sci, Dept Mol. Med., Div. Biochem.

University of Oslo Feb 01 2003 - Dec 31 2016

Norway

Director and Professor :: Biotechnology Centre of Oslo

Publications

Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise-Lotte Flage-Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways. Molecular oncology (2024)
Ivana Spasevska, Ankush Sharma, Chloé Beate Steen, Sarah E Josefsson, Yngvild Nuvin Blaker, Arne Kolstad, Even Holth Rustad, Saskia Meyer, Kathrine T Isaksen, Stalin Chellappa, Kushi Kushekhar, Klaus Beiske, Mette S Førsund, Signe Spetalen, Harald Holte, Bjorn Ostenstad, Marianne Brodtkorb, Eva K Kimby, Johanna Olweus, Kjetil Taskén, Aaron M Newman, Susanne Lorenz, Erlend B Smeland, Ash A Alizadeh, Kanutte Huse, June Helen Myklebust
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood advances (2023)
Pilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes, Sandra L Gordon, Heikki Kuusanmäki, Andrea M Brodersen, Aram N Andersen, Kjetil Taskén, Krister Wennerberg, Jorrit M Enserink, Sigrid S Skånland
Standardized assays to monitor drug sensitivity in hematologic cancers. Cell death discovery 9 (1) (2023)
Jonas Skogestad, Ingrid Albert, Karina Hougen, Gustav B Lothe, Marianne Lunde, Olav Søvik Eken, Ioanni Veras, Ngoc Trang Thi-Huynh, Mira Børstad, Serena Marshall, Xin Shen, William Edward Louch, Emma Louise Robinson, Joseph C Cleveland, Amrut V Ambardekar, Jessica A Schwisow, Eric Jonas, Ana Isabel Costa Calejo, Jens Preben Morth, Kjetil Taskén, Arne Olav Melleby, Per Kristian Lunde, Ivar Sjaastad, Cathrine Rein Carlson, Jan Magnus Aronsen
Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure. Circulation (2023)
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali, Stacey M Fernandes, Alberto J Arribas, Abdul K Hilli, Kjetil Taskén, Francesco Bertoni, Anthony R Mato, Emmanuel Normant, Jennifer R Brown, Geir Erland Tjønnfjord, Tero Aittokallio, Sigrid S Skånland
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Elisa Bjørgo, Silje A Solheim, Hilde Abrahamsen, George S Baillie, Kim M Brown, Torunn Berge, Klaus Okkenhaug, Miles D Houslay, Kjetil Taskén
Correction for Bjørgo et al., "Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/β-Arrestin/cAMP Phosphodiesterase 4 Complex". Molecular and cellular biology 42 (2) (2022)
Mariaserena Giliberto, Deepak B Thimiri Govinda Raj, Andrea Cremaschi, Sigrid S Skånland, Alexandra Gade, Geir E Tjønnfjord, Fredrik Schjesvold, Ludvig A Munthe, Kjetil Taskén
Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. Molecular oncology 16 (6) (2022)
Kjetil Taskén, Hege E G Russnes, Eline Aas, Line Bjørge, Egil S Blix, null null, Espen Enerly, Gro L Fagereng, Åsmund Flobak, Bjørnar Gilje, Bjorn Tore Gjertsen, Tormod K Guren, Jutta Heix, Eivind Hovig, Randi Hovland, null null, null null, Per E Lønning, Leonardo A Meza-Zepeda, Per M Mæhle, Hilde L Nilsen, Steinar Ø Thoresen, Ketil Widerberg, Sigbjørn Smeland, Åslaug Helland
A national precision cancer medicine implementation initiative for Norway. Nature medicine 28 (5) (2022)
Qian Wei, Kjetil Taskén
Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development. The Biochemical journal 479 (20) (2022)
Stalin Chellappa, Kushi Kushekhar, Morten Hagness, Rune Horneland, Kjetil Taskén, Einar Martin Aandahl
The Presence of Activated T Cell Subsets prior to Transplantation Is Associated with Increased Rejection Risk in Pancreas Transplant Recipients. Journal of immunology (Baltimore, Md. : 1950) 207 (10) (2021)
Xiaojun Jiang, Annika Bergquist, Britt-Sabina Petersen, Geetha Venkatesh, Jeff E Mold, Kristian Holm, Jon Kristen Laerdahl, Sigrid S Skånland, Kimia T Maleki, Martin Cornillet Jeannin, Kjetil Taskén, Andre Franke, Tom H Karlsen, Niklas K Björkström, Espen Melum
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis. Science translational medicine 13 (582) (2021)
Katrine Melvold, Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda-Durán, Robert Hanes, Toril Holien, Jorrit Enserink, Jennifer R Brown, Geir E Tjønnfjord, Kjetil Taskén, Sigrid S Skånland
Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B cell malignancies. Molecular oncology (2021)
Anna Mari Lone, Piero Giansanti, Marthe Jøntvedt Jørgensen, Enio Gjerga, Aurélien J F Dugourd, Arjen Scholten, Julio Saez-Rodriguez, Albert J R Heck, Kjetil Taskén
Systems approach reveals distinct and shared signaling networks of the four PGE2 receptors in T cells. Science signaling 14 (703) (2021)
Anna Mari Lone, Kjetil Taskén
Phosphoproteomics-Based Characterization of Prostaglandin E2 Signaling in T Cells. Molecular pharmacology 99 (5) (2021)
Synne Jenum, Kristian Tonby, Corina Silvia Rueegg, Morten Rühwald, Max P Kristiansen, Peter Bang, Inge Christoffer Olsen, Kjersti Sellæg, Kjerstin Røstad, Tehmina Mustafa, Kjetil Taskén, Dag Kvale, Rasmus Mortensen, Anne Margarita Dyrhol-Riise
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients. Nature communications 12 (1) (2021)
Sigrid S Skånland, Linda Karlsen, Kjetil Taskén
B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia. Scandinavian journal of immunology 92 (5) (2020)
Sigrid S Skånland, Kjetil Taskén
Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling. Journal of immunology (Baltimore, Md. : 1950) 203 (4) (2019)

Kjetil Taskén.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kjetil Taskén